Federal Circuit rules that Argentum cannot pursue its appeal of a PTAB decision declining to institute an inter-partes review, even though Argentum might be estopped to challenge the patent in subsequent Hatch Waxman litigation

April 27, 2020

Federal Circuit affirms trial court decision that dose could have been arrived at by routine experimentation.

April 13, 2020

Federal Circuit affirms PTAB decision that the use of a surfactant to prevent aggregation of insulin glargine would have been obvious.

April 07, 2020